BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA PRIME Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta

  December 12, 2024

   · 

  7 min read
• Press Releases

  Biomea Fusion Announces Oral and Poster Presentations of Icovamenib at the 22nd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)

  December 12, 2024

   · 

  10 min read
• Press Releases

  iSpecimen Appoints Robert Lim as CEO and Director

  December 12, 2024

   · 

  4 min read
• Press Releases

  Gilead Sciences Appoints Dietmar Berger, MD, PhD, as Chief Medical Officer

  December 12, 2024

   · 

  4 min read
• Press Releases

  Sharp Therapeutics Corp. Announces Completion of Qualifying Transaction

  December 12, 2024

   · 

  9 min read
• Press Releases

  Cancer Peptide Drugs Market US$ 18 Billion Opportunity

  December 12, 2024

   · 

  1 min read
• Press Releases

  Emerging Role Of CD40 In Overcoming Resistance To Immunotherapy

  December 12, 2024

   · 

  1 min read
• Press Releases

  Targeted Alpha Therapy Market Clinical Trials Proprietary Technologies Insight

  December 12, 2024

   · 

  1 min read
• Press Releases

  CD40 Targeting Therapies Clinical Trials Therapeutic Approaches Insight

  December 12, 2024

   · 

  1 min read
• Press Releases

  Global Cancer Antibody Drug Conjugates Market US$ 50 Billion Opportunity By 2030

  December 12, 2024

   · 

  1 min read